T. Rowe Price Investment Management, Inc. Ptc Therapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 174,088 shares of PTCT stock, worth $7.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
174,088Holding current value
$7.9 Million% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
298Shares Held
79.4MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$353 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$340 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$247 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$246 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.25B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...